Chris Pasquale
Stock Analyst
(n/a)
# 4,649
Out of 4,649 analysts
6
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Pasquale
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZIMV ZimVie | Initiates: Neutral | n/a | $14.36 | - | 1 | Mar 18, 2022 | |
| ICAD iCAD, Inc. | Downgrades: Neutral | n/a | $1.89 | - | 2 | Jan 18, 2022 | |
| DXCM DexCom | Upgrades: Buy | $145 | $68.91 | +110.42% | 1 | Jan 7, 2022 | |
| COO The Cooper Companies | Upgrades: Buy | $124 | $103.33 | +19.76% | 1 | Jan 3, 2022 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $45 | $96.23 | -53.24% | 1 | Oct 11, 2021 |
ZimVie
Mar 18, 2022
Initiates: Neutral
Price Target: n/a
Current: $14.36
Upside: -
iCAD, Inc.
Jan 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.89
Upside: -
DexCom
Jan 7, 2022
Upgrades: Buy
Price Target: $145
Current: $68.91
Upside: +110.42%
The Cooper Companies
Jan 3, 2022
Upgrades: Buy
Price Target: $124
Current: $103.33
Upside: +19.76%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $45
Current: $96.23
Upside: -53.24%